Cart
sales@molnova.com
Risedronate Sodium
CAS No. 115436-72-1
Risedronate Sodium ( —— )
Catalog No. M10542 CAS No. 115436-72-1
Risedronate Sodium, a nitrogen-containing bisphosphonate, inhibits osteoclast-mediated bone resorption and modulates bone metabolism, used in the treatment of osteoporosis.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 39 | In Stock |
|
| 100MG | 65 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRisedronate Sodium
-
NoteResearch use only, not for human use.
-
Brief DescriptionRisedronate Sodium, a nitrogen-containing bisphosphonate, inhibits osteoclast-mediated bone resorption and modulates bone metabolism, used in the treatment of osteoporosis.
-
DescriptionRisedronate Sodium, a nitrogen-containing bisphosphonate, inhibits osteoclast-mediated bone resorption and modulates bone metabolism, used in the treatment of osteoporosis.
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHBV
-
RecptorHAP; FPS
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number115436-72-1
-
Formula Weight305.09
-
Molecular FormulaC7H10NNaO7P2
-
Purity>98%(HPLC)
-
SolubilityWater: 2 mg/mL (6.55 mM)
-
SMILESO.O.O.O.O.[Na+].OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)([O-])=O.OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)([O-])=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bergstrom JD, et al. Arch Biochem Biophys. 2000 Jan 1;373(1):231-4
molnova catalog
related products
-
Hepatitis B Virus Co...
The hepatitis B virus (HBV) core protein has been found in the nucleus, the cytoplasm, or both of HBV-infected hepatocytes. nuclear localization of the HBV core protein is negatively regulated by phosphorylation during the cell cycle.
-
NTCP binder peptide ...
NTCP binder peptide WL4 is a macrocyclic peptide, pan-genotypic inhibitor of HBV cellular entry via targeting the cell-surface receptor for HBV.
-
Besifovir
Besifovir (PMCDG Dipivoxil, NA-380, LB-80380) is a potent, selective, orally available anti-HBV agent, the prodrug of PMCDG (EC50=4 uM).
